KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Sustained resolution of enthesitis and peripheral arthritis over 104 weeks with bimekizumab in axial spondyloarthritis.

RMD Open · 2025-Oct-22 · PMID 41125403

Panel Mean_SJC_SEM_质量警告待 EXE 对齐验证

SJC (Swollen Joint Count)

Graphical summary of study results. a BKZ-randomised patients; b BKZ-randomised and placebo-switched patients; c placebo-randomised patients. axSpA, axial spondyloarthritis; BKZ, bimekizumab; DAPSA, Disease Activity Index in Psoriatic Arthritis; LDA, low disease activity; MASES: Maastricht Ankylosing Spondylitis Enthesitis Score; MI: multiple imputation; nr-axSpA: non-radiographic axSpA; NRI: non-responder imputation; OC: observed case; PBO: placebo; r-axSpA: radiographic axSpA; REM: remission; SJC: swollen joint count.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分1.00
质量通过否
预期曲线2
实际曲线1
X 范围-
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0quality_warning待验证12026-07-23T18:00:19+00:00